Yuval Patel

Dr. Yuval A. Patel is a board-certified gastroenterologist and transplant hepatologist. He has expertise in the diagnosis and management of GI and liver disorders. His care philosophy centers on patients feeling empowered about their own medical care. He strives to partner with patients to develop the best care plan for each of them. 


Dr. Patel graduated magna cum laude with a B.S. in Biology from Duke University. He earned his medical degree at the Johns Hopkins University School of Medicine, which was followed by internal medicine residency at Johns Hopkins Hospital. He subsequently completed his gastroenterology and transplant hepatology fellowships at Duke Hospital, and completed a masters of health sciences in clinical research at that time.


Prior to joining Borland Groover he worked as academic faculty at Duke University Hospital in the GI division, serving as Medical Director of the main hospital-based GI clinic. He has a specific research interest in liver diseases, which has led to numerous presentations at national meetings and over 50 peer-reviewed publications.


When he is not practicing medicine, he enjoys traveling and outdoor activities with his wife and two young children.

Postgraduate Education
Internal Medicine Residency
Johns Hopkins Hospital
2014 - 2017
Gastroenterology and Hepatology Fellowship
Duke University Medical Center
2017 - 2018
Transplant Hepatology Fellowship
Duke University Medical Center

1. ​Patel YA, Dhalla S, Olson M, Lennon A, Khashab MA, Singh VK. Pancreatic Metastasis from a Solitary Fibrous Tumor of the Kidney: A Rare Cause of Acute Recurrent Pancreatitis. Pancreatology. 2013 Nov-Dec; 13(6): 631-3.
2. Tieu AH, Kumbhari V, Jakhete N, Onyimba F, Patel YA, Shin EJ, Li Z. Diagnostic and therapeutic utility of Spyglass peroral cholangioscopy in intraductal biliary disease: single-center, retrospective, cohort study. Dig Endosc. 2015 May; 27(4): 479-85.
3. Kumbhari V, Sinha A, Reddy A, Afghani E, Cotsalas D, Patel YA, Storm AC, Khashab MA, Kalloo AN, Singh, VK. Algorithm for the management of ERCP-related perforations. Gastrointest Endosc. 2015 May;83(5):934-43.
4. Holly BP, Patel YA, Park J, Fayad LM, Deune EG, Mitchell SE, Weiss CR. Preoperative epoxy embolization facilitates safe and effective resection of venous malformations in the hand and forearm. Hand. In Press 2016.
5. Sinha A, Patel YA, Cruise M, Matsukuma K, Zaheer A, Afghani E, Yadav D, Makary MA, Hirose K, Andersen DK, Singh VK. Predictors of post-operative pain relief in patients with chronic pancreatitis undergoing the Frey or Whipple procedure. J Gastrointest Surg. 2016 Apr; 20(4):734-40.
6. Anand G, Patel YA, Yeh HC, Khashab M, Lennon AM, Shin EJ, Canto MI, Okolo PI, Kalloo A, Singh VK. Factors and Outcomes Associated with MRCP Use prior to ERCP in Patients at High Risk for Choledocholithiasis. Can J Gastroenterol Hepatol. 2016; 2016:5132052.
7. Patel YA, Berg CL, Moylan CA. Nonalcoholic fatty liver disease: Key considerations before and after liver transplantation. Dig Dis Sci. 2016 May; 61(5):1406-16.
8. Patel YA, McCall SJ, Zhang X, Jaffe T, Shimpi RA. Radiographic and endoscopic regression of metastatic gastric cancer to the colon in the setting of 5-aminosalicylic acid use. J Gastrointest Oncol. In Press 2016 May 20.
9. Patel YA, Berg CL, Moylan CA. Liver Transplantation for Nonalcoholic Fatty Liver Disease: Role of Bariatric Surgery for Comorbid Obesity. J Adv Nutr Hum Metab 2016; 2:e1327. 2016 May 30.
10. Patel YA, Muir AJ. Evaluation of New-Onset Ascites. JAMA. 2016 Jul 19; 316(3):340-1.
11. Niranjan-Azadi AM, Araz F, Patel YA, Alachkar N, Alqahtani S, Cameron AM, Stevens RD, Gurakar A. Ammonia Level and Mortality in Acute Liver Failure: A Single-Center Experience. Ann Transplant. 2016 Aug 2;21:479-83. 5
12. Patel YA*, Chan AW*, Choi S. (*Co-First Authors). Aging of the Liver: What this Means for Patients with HIV. Curr HIV/AIDS Rep. In Press 2016 Aug 25.
13. Patel YA, Henao R, Moylan CA, Guy CD, Piercy DL, Diehl AM, Abdelmalek MF. Vitamin D is not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis. Am J Gastroenterol. 2016 Nov; 111(11):1591-98.
14. Patel YA, Muir AJ. Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-acting Retrovirals. Curr Hepatology Rep. 2016 Dec; 15:285-290.
15. Henson JB, Patel YA, King LY, Zheng J, Chow SC, Muir AJ. Outcomes of Liver Re-transplantation in Patients with Primary Sclerosing Cholangitis. Liver Transpl. 2016 Dec 27.
16. Henson JB, Patel YA, Wilder JM, Zheng J, Chow SC, King LY, Muir AJ. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. Dig Dis Sci. 2017 Apr 8; Epub ahead of print.
17. Patel YA, Gifford EJ, Glass LM, McNeil R, Turner MJ, Han B, Provenzale D, Choi SS, Moylan CA, Hunt CM. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration. Aliment Pharmacol Ther. 2018 Jan;47(2):268-278.
18. Faghih M, Sinha A, Moran R, Afghani E, Patel YA, Storm A, Kamal A, Kumbhari V, Kalloo A, Singh VK. Length of stay overestimates the severity of post-ERCP pancreatitis: is it time to revise the consensus definition? Endoscopy International Open. 2018 july;6(7):E838-E843.
19. Patel YA, Wegermann K, Berg CL, King LY. Our patient with decompensated NASH cirrhosis with inability to lose weight should undergo transplantation. Clinical Liver Disease. 2018 July 26; 11(6):149-151.
20. Patel YA, Gifford EJ, Glass LM, McNeil R, Turner MJ, Han B, Provenzale D, Choi SS, Moylan CA, Hunt CM. Identifying non-alcoholic fatty liver disease advanced fibrosis in the Veterans Health Administration. Dig Dis Sci. 2018 May 19. Epub ahead of print.
21. Patel YA, Henson JB, Wilder JM, Zheng J, Chow SC, Berg CL, Knechtle SJ, Muir AJ. The impact of HLA donor and recipient serotyping and matching on liver transplant graft failure in PSC, AIH, and PBC. Clin Transplant. 2018 Oct;32(10):e13388.
22. Finn RT, Lloyd B, Patel YA, Allen JT, Cornejo J, Davis A, Mcintosh T, Ferguson S, Sims K, Sudaj S, Taheri J, Burr NA, Provenzale D, Gellad ZF. Decreasing endoscopy no-shows using a lean improvement framework. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1224-1227.
23. Zheng X, Burroughs S, Farooq A, Bashir MR, Muir AJ, Patel YA. N-Acetylcysteine in the management of ALF from sickle cell hepatic crisis. ACG Case Rep J. 2019 Aug 21;6(8):e00161
24. Patel YA*, Verna EC, Aggarwal A, Desai AP, Frenette C, Pillai AA, Salgia R, Seetharam A, Sharma P, Sherman C, Tsoulfas G, Yao FY. Liver Transplantation for HCC: Management after Transplant. Am J Transplant. 2019 Nov 11. epub ahead of print. *co-first authors.
25. Henson JB, Wilder JM, Kappus MR, Barbas AS, Moylan CA, Niedzwiecki D, Muir AJ, Berg CL, Patel YA. Transplant outcomes in older patients with Nonalcoholic steatohepatitis compared to Alcohol-related liver disease and Hepatitis C. Transplantation. 2020 Mar 6. doi:10.1097.
26. Kesseli, SJ, Samoylova ML, Yerxa J, Moore CB, Cerullo M, Gao Q, Abraham N, Patel YA, McElroy LM, Vikraman D, Barbas AS. Donor-Recipient Height Mismatch is Associated with Decreased Survival in Pediatric-to-Adult Liver Transplant Recipients. 2020 Nov 14. Epub ahead of print PMID: 33188659.
27. Kwong AJ, Devuni D, Wang C, Boike J, Jo J, VanWagner L, Serper M, Jones L, Sharma R, Verna EC, Shor J, German NM, Hristov A, Lee A, Spengler E, Koteish AA, Sehmbey G, Seetharam A, John N,
Patel YA, Kappus MR, Couri T, Paul S, Salgia RJ, Nhu Q, Frenette CT, Lai JC, Goel A. Outcomes of liver transplantation among older recipients with NASH in a large multicenter US cohort: the re-evaluating age limits in transplantation consortium. Liver Transpl. 2020 Nov; 26(11):1492-1503.
28. Patel YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, Goacher E, Muir AJ. Reduced alcohol use is sustained in patients provided alcohol-related counseling during direct-acting antiviral therapy for Hepatitis C. Dig Dis Sci. 2020 Sep 23. Epub ahead of print. PMID 32968965.
29. Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich N, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami Pi, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. Provider attitudes toward risk-based hepatocellular carcinoma surveillance in patients with cirrhosis in the US. Clin Gasteroenterol Hepatol. 2020 Sep 11;S1542-3565(20)31272-6.
30. Park C, Patel YA, Suhocki P, Dorsey C, Kapila N, Tang L, Gilner J. High-risk third trimester pregnancy with decompensated cirrhosis safely delivered following emergent preoperative interventional radiology for mitigation of variceal bleeding. Clin Imaging. 2020 Dec68: 143-147.
31. Moris D, Shaw BL, Gloria J, Kesseli SJ, Samoylova ML, Schmitz R, Manook M, McElroy LM, Patel YA, Berg CL, Knechtle SJ, Sudan DL, Barbas AS. Textbook outcomes in liver transplantation. World J Surg. 2020 Oct:44(10):3470-77.
32. Kappus MR, Wegermann K, Bozdogan E, Patel YA, Janas G, Shropshire E, Parish A, Niedzwiecki D, Muir AJ, Bashir M. Use of skeletal muscle index as predictor of wait-list mortality in patients with end-stage liver disease. Liver Transpl. 2020 Sep:26(9):1090-1099.
33. Kapila N, Dorsey YC, Shah J, King L,Ravindra K, Knechtle S, Patel YA. Transjugular intrahepatic portosystemic shunt for a challenging pregnancy. Am J Gastroenterol. 2020 Dec 115(12):1935. Barman PM, King LY, Berg CL, Parish A, Niedzwiecki D, Barbas AS, McElroy L, Patel YA. Need for pretransplant midodrine does not negatively impact simultaneous liver-kidney transplant outcomes. Transplant Direct. 2020 Dec 15;7(1):e640
34. Wegermann K, Wilder JM, Parish A, Niedzwiecki D, Gellad CF, Muir AJ, Patel YA. Racial and socioeconomic disparities in utilization of telehealth in patients with liver disease during COVID-19. Dig Dis Sci. 20201 Jan 28:1-7.
35. Couzi L, Manook M, Caillard S, Epally E, Barrou B, Anglicheau D, Buchler M, Mussot S, Dumortier J, Thaunat O, Sebbag L, Blancho G, Le Meur Y, Patel YA, Samoylova M, McElroy L, Shawl BL, Sanoff S, Hazzan M. Impact of COVID-19 on kidney transplant and waiting list patients: Lessons from the first wave of the pandemic. Nephrol Ther. 2021 Jan 8:S1769-7255(21)00006-7.
36. Sharma P, Sui Z, Zhang M, Magee JC, Barman P, Patel YA, Schluger A, Walter K, Biggins SW, Cullaro G, Wong R, Lai JC, Jo J, Sinha J, VanWagner L, Verna EC. Renal outcomes after simultaneous liver-kidney transplantation: Results from the US multicenter simultaneous liver-kidney transplantation consortium. Liver Transpl. 2021 Feb 28.
37. Samoylova ML, Wegermann K, Shaw BL, Kesseli SJ, Au S, Park C, Halpern SE, Sanoff S, Barbas AS, Patel YA, Sudan DL, Berg C, McElroy LM. The impact of the 2017 kidney allocation policy change on simultaneous liver kidney utilization and outcomes. Liver Transpl. 2021 Mar 18.
38. Barman PM, King LY, Berg CL, Parish A, Niedzwiecki D, Barbas AS, McElroy L, Patel YA. Need for pretransplant midodrine does not negatively impact simultaneous liver-kidney transplant outcomes. Transplant Direct. 2020 Dec 15;7(1):e640
39. Wegermann K, Patel Y, Wilder J. Healthy Equity and Telemedince in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2021. Aug:19(8):1516-19.
40. Modi K, Segovia M, Mavis A, Schiano T, Patel Y, Boike J, Sudan D, Nagai S, Jafri SM. Efficacy and safety of mammalian target of rapamycin inhibitors following intestinal and multivisceral transplantation. Clin Transplant. 2021 July:35(7):e14324.
41. Cullaro G, Sharma P, Jo J, Rassiwala J, VanWagner LB, Wong R, Lai JC, Magee J, Schluger A, Barman P, Patel YA, Walter K, Biggins SW, Verna EC. Temporal trends and evolving outcomes after simultaneous liver-kidney transplantation: results from the US SLKT consortium. Liver Transpl. 2021 Nov;27(11):1613-22.
42. Halpern SE, Samoylova ML, Shaw BL, Kesseli SJ, Hartwing MG, Patel YA, McElroy LM, Barbas AS. Reexamining risk aversion: willingness to pursue and utilize nonideal donor livers among US donation service areas. Transplant Direct. 2021 Aug 6;7(9):e742.
43. Fung BM, Perumpail M, Patel YA, Tabibian JH. Telemedicine in Hepatology: Current Applications and Future Directions. Liver Transpl. 2022 Feb:28(2):294-303.
44. Henson JB, Patel YA, Muir AJ. Trends in statin utilization in US adults with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021 Dec:54(11-12):1481-89.
45. Helzberg JH, Parish A, Niedzwiecki D, Kim CY, Patel YA, Wilder JM, Muir AJ. Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes. BMJ Open Gastroenterol. 2022 Jan:9(1):e000747.
46. Gonzalez JJ, Dziwis J, Patel YA, Tapper EB. Identifying ascites in patients with cirrhosis using administrative codes and diuretic use: a multicenter study. Dig Dis Sci. 2022 Jan 28. 7
47. Barman PM, Patel YA, Xie J, et al. Predictors of length of stay and mortality during simultaneous liver-kidney transplant index admission: Results from the US-Multicenter SLKT Consortium. Transplant Direct. 2002 Nov 11;8(12):e1408.
48. Jo J, Crespo G, Gregory D, Sinha J, Xie J, Zhang M, Barman P, Patel YA, et al. Factors associated with cardiovascular events after simultaneous liver-kidney transplant from the US Multicenter Simultaneous Liver-Kidney Transplant Consortium. Hepatol Commun. 2002 Oct 26;7(1):e2108.
49. Sharma P, Xie J, Wang L, Zhang M, Magee J, Answine A, Barman P, Jo J, Sinha J, Schluger A, Perreault GJ, Walters KE, Cullaro G, Wong R, Filipek N, Biggins SW, Lai JC, VanWagner LB, Verna EC, Patel YA. Burden of early hospitalization after simultaneous liver-kidney transplantation: results from the US Multicenter SLKT Consortium. Liver Transpl. 2022 Nov;28(11):1756-1765.
50. Henson JB, Wegermann K, Patel YA, Wilder JM, Muir AJ. Access to technology to support telehealth in areas without specialty care for liver disease. Hepatology 2023. Jan 1;77(1):176-185.
51. Currier EE, Ichkanian Y, Dabaja M, Segovia MC, Patel YA, Nagai S, Sudan DL, Jafri SM. Cytomegalovirus infection management in multivisceral and intestinal transplant: a dual institution study. Transplant Proc. 2023 Mar;55(2):413-16